← Back to Clinical Trials
Recruiting NCT06760754

NCT06760754 Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06760754
Status Recruiting
Phase
Sponsor M.D. Anderson Cancer Center
Condition Cancer
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-03-31
Primary Completion 2028-01-01

Trial Parameters

Condition Cancer
Sponsor M.D. Anderson Cancer Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-03-31
Completion 2028-01-01
Interventions
Digital culinary medicine intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this study is to develop and test the feasibility of a theory-driven digital culinary medicine program among food insecure cancer survivors referred from the University of Texas MD Anderson Cancer Center Oncology Clinic at LBJ to the LBJ Food Farmacy program.

Eligibility Criteria

Inclusion Criteria: * Cancer survivors treated at the MD Anderson Oncology Program at LBJ Hospital over 18 years of age. * Screen positive for food insecurity using the 2 question clinic-screener (Hunger Vital Signs) * Receive referral to the LBJ Food Farmacy. * Are within the first 5 years off of acute cancer treatment. * Self-report having internet access. * Self-report as being able to speak and read English or Spanish. * Willing to complete study assessments. Exclusion Criteria: * Unwilling or unable to complete study assessments * Anyone under 18 years of age * Self-report to not speak or read English or Spanish

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology